Hypoproteinemia in Patients with Diabetes Undergoing Continuous Ambulatory Peritoneal Dialysis is Attributable to High Permeability of Peritoneal Membrane

Abstract

Background

The present study used the newly developed personal dialysis capacity (PDC) peritoneal function test to investigate differences in individual peritoneal membrane transport function and nutritional status in non diabetic (non DM) and diabetic (DM) patients on continuous ambulatory peritoneal dialysis (CAPD).

Patients and Methods

To clarify the differences in peritoneal function that determine plasma protein levels, we carried out PDC tests in non DM and DM patients. Between May 1995 and May 1999, in multicenter study in Japan, we carried out 232 PDC tests on 232 non DM patients and 47 PDC tests on 47 DM patients who had been on CAPD for 1 – 210 months.

Results

Plasma levels of total protein and albumin in DM patients were significantly lower than those in non DM patients (total protein: 6.5 ± 0.1 g/dL non DM vs. 5.9 ± 0.1 g/dL DM, p < 0.0001; albumin: 3.5 ± 0.1 g/dL non DM vs. 2.9 ± 0.1 g/dL DM, p < 0.0001). The mean membrane area in the DM group was significantly larger than that in the non DM group (21943 ± 608 cm/1.73 m² non DM vs. 26 304 ± 1699 cm/1.73 m² DM, p = 0.0076). The mean plasma loss through the large pores in the DM group was significantly greater than that in the non DM group (0.095 ± 0.004 mL/min/1.73 m² non DM vs. 0.119 ± 0.008 mL/min/1.73 m² DM, p = 0.0113). Protein loss into dialysate in DM patients was significantly greater than that in non DM patients. We observed a significant correlation between total protein or albumin and plasma loss from dialysis solution in non DM and DM patients on CAPD.

Conclusions

The study demonstrated that peritoneal function, including peritoneal membrane transport and peritoneal permeability to protein was significantly higher in DM patients than in non DM patients. Hypoproteinemia in DM patients might be associated with high permeability of peritoneal membrane in CAPD.

Keywords

Diabetes nutrition total protein albumin continuous ambulatory peritoneal dialysis personal dialysis capacity (PDC) test

Get full access to this article

View all access options for this article.

References

Foley

R.N.

, Parfrey

P.S.

, Harnett

J.D.

, Kent

G.M.

, Murray

D.C.

, Barré

P.E.

Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease.

J Am Soc Nephrol 1996; 7: 728–36.

Foley

R.N.

, Parfrey

P.S.

, Harnett

J.D.

, Kent

G.M.

, Martin

C.J.

, Murray

D.C.

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.

Kidney Int 1995; 47: 186–92.

Sezer

, Ozdemir

F.N.

, Akman

, Arat

, Anaforoglu

, Haberal

Predictors of serum albumin level in patients receiving continuous ambulatory peritoneal dialysis.

Adv Perit Dial 2001; 17: 210–14.

Rippe

A three-pore model of peritoneal transport.

Perit Dial Int 1993; 13: S35–8.

Haraldsson

Assessing the peritoneal dialysis capacities of individual patients.

Kidney Int 1995; 47: 1187–98.

Nakamoto

, Imai

, Kawanishi

, Nakamoto

, Minakuchi

, Kumon

Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.

Adv Perit Dial 2001; 17: 238–43.

Schaffer

, Haraldsson

, Haas

, Simkova

, Feber

, Mehls

Estimation of peritoneal mass transport by three-pore model in children.

Kidney Int 1998; 54: 1372–9.

Matsushita

, Nishikimi

, Sakurai

, Yano

, Nimura

Urinary microalbumin as a marker for intermittent claudication.

Eur J Vasc Endovasc Surg 1996; 11: 421–4.

Doumas

B.T.

, Watson

W.A.

, Biggs

H.G.

Albumin standards and the measurement of serum albumin with bromcresol green.

Clin Chim Acta 1971; 31: 87–96.

10.

Twardowski

Z.J.

, Nolph

K.D.

, Khanna

, Prowant

B.F.

, Ryan

L.P.

, Moore

H.L.

Peritoneal equilibration test.

Perit Dial Bull 1987; 7: 138–47.

11.

Kagan

, Bar-Khayim

, Schafer

, Fanaru

Heterogeneity in peritoneal transport during continuous ambulatory peritoneal dialysis and its impact on ultrafiltration, loss of macromolecules and plasma level of proteins, lipids and lipoproteins.

Nephron 1993; 63: 32–43.

12.

Lamb

E.J.

, Worrall

, Buhler

, Harwood

, Cattell

W.R.

, Dawnay

A.B.

Effect of diabetes and peritonitis on the peritoneal equilibration test.

Kidney Int 1995; 47: 1760–7.

13.

Blumenkrantz

M.J.

, Gahl

G.M.

, Kopple

J.D.

, Kamdar

A.V.

, Jones

M.R.

, Kessel

Protein losses during peritoneal dialysis.

Kidney Int 1981; 19: 593–602.

14.

Dulaney

J.T.

, Hatch

F.E.

Peritoneal dialysis and loss of proteins: A review.

Kidney Int 1984; 25: 107–14.

15.

Bollinger

, Frey

, Jager

, Furrer

, Seglias

, Siegenthaler

Patterns of diffusion through skin capillaries in patients with long-term diabetes.

N Engl J Med 1982; 307: 1305–10.

16.

Kaysen

G.A.

, Schoenfeld

P.T.

Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis.

Kidney Int 1984; 25: 107–14.

17.

Serlie

M.J.

, Struijk

D.G.

, de Blok

, Krediet

R.T.

Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.

Adv Perit Dial 1997; 13: 29–32.

18.

Parving

H.H.

Increased microvascular permeability to plasma proteins in short- and long-term juvenile diabetics.

Diabetes 1976; 25(Suppl): 884–9.

19.

Peterson

G.E.

, Forsham

P.H.

Variation in thickness of the capillary basement membrane in single muscles of diabetic subjects.

Diabetes 1979; 28: 548–51.

20.

Young

G.A.

, Kopple

J.D.

, Lindholm

, Vonesh

E.F.

, De Vecchi

, Scalamogna

Nutritional assessment of continuous ambulatory dialysis patients: An international study.

Am J Kidney Dis 1991; 17: 462–71.

21.

Hoffer

L.J.

Starvation. In: Shils

M.E.

, Young

V.R.

, eds. Modern Nutrition in Health and Disease. 7th ed. Philadelphia: Lea and Febiger; 1988: 774–94.

22.

Blake

P.G.

, Flowerdew

, Blake

R.M.

, Oreopoulos

D.G.

Serum albumin in patients on continuous ambulatory peritoneal dialysis—predictors and correlations with outcome.

J Am Soc Nephrol 1993; 3: 1501–7.

23.

Struijk

D.G.

, Krediet

R.T.

, Koomen

G.C.

, Boeschoten

E.W.

, Arisz

The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival.

Perit Dial Int 1994; 14: 121–6.

24.

Churchill

D.N.

, Taylor

D.W.

, Keshaviah

P.R.

, and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198–207.